RAC 5.76% $1.64 race oncology ltd

Ann: Race releases complete cardio-protection data & video, page-204

  1. 521 Posts.
    lightbulb Created with Sketch. 268
    really good argument and in this day and age, "porque no los dos?", why can't we have both ?

    Triangle discounted the cardio protect value by 50%, so why can't we have one BP paying 50% upfront, USD5-8B, and the remaining 50%, $5-8B, paid out in royalties on a sliding scale, ie. majority paid out in bisantrene's patent life and less when generics come into play?

    same goes for FTO and $1B AML

    certainly a lot more digestible...

    AbbVie paid USD22B for only 50% of Pharmacyclics and the other 50% was owned by J&J, instos and SHs who enjoyed royalties/divies of some sort
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.64
Change
-0.100(5.76%)
Mkt cap ! $278.5M
Open High Low Value Volume
$1.71 $1.71 $1.64 $205.3K 123.0K

Buyers (Bids)

No. Vol. Price($)
1 1526 $1.64
 

Sellers (Offers)

Price($) Vol. No.
$1.65 234 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.